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Abstract
Objective
The objective of the study was to analyse placental hormone profiles in twin pregnancies to
determine if they could be used to predict preterm birth.
Study design
Progesterone, estradiol, estriol and corticotropin-releasing hormone were measured using
competitive immunoassay and radioimmunoassay in serum and saliva samples of 98
women with twin pregnancies,at 3 or more gestational timepoints. Hormone profiles
throughout gestation were compared between very preterm (<34 weeks; n = 8), preterm
(<37 weeks; n = 40) and term (37+ weeks; n = 50) deliveries.
Results
No significant differences were found between preterm and term deliveries in either absolute
hormone concentrations or ratios. Estimated hormone concentrations and ratios at 26
weeks did not appear to predict preterm delivery. Salivary and serum hormone concentra-
tions were generally poorly correlated.
Conclusion
Our results suggest that serial progesterone, estradiol, estriol and corticotropin-releasing
hormone measurements in saliva and serum are not robust biomarkers for preterm birth in
twin pregnancies.
PLOS ONE | DOI:10.1371/journal.pone.0173732 March 9, 2017 1 / 13
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Lim H, Powell S, Mcnamara HC, Howie
AF, Doust A, Bowman ME, et al. (2017) Placental
hormone profiles as predictors of preterm birth in
twin pregnancy: A prospective cohort study. PLoS
ONE 12(3): e0173732. doi:10.1371/journal.
pone.0173732
Editor: Gijs B Afink, Academic Medical Centre,
University of Amsterdam, NETHERLANDS
Received: October 18, 2016
Accepted: February 24, 2017
Published: March 9, 2017
Copyright: © 2017 Lim et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in
any medium, provided the original author and
source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: The research was funded by the Albert
McKern Bequest, administered by the University of
Edinburgh, and Tommy’s Baby Charity. The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
Competing interests: JEN and SJS report grant
funding to prevent preterm birth in women with
Introduction
Multiple pregnancies result in significant neonatal mortality five to six times greater than that
of singletons [1]. Preterm birth (PTB) is the biggest single contributing factor to this. More
than half (56%) of multiple pregnancies deliver before 37 weeks’ gestation, compared to just
6% of singletons [2]. Compared to singletons, surviving twins experience a higher risk of respi-
ratory distress, hypothermia, seizures and rehospitalization, as well as motor and cognitive
problems in childhood [3].
The lack of adequate screening methods or preventative measures for those multiple preg-
nancies at high risk of spontaneous PTB presents a major challenge. While mechanisms such
as increased uterine stretch, elevated placental corticotropin-releasing hormone (CRH), fetal
lung factors, infection, stress, cervical insufficiency and placental dysfunction have been pro-
posed to explain the higher PTB rate in multiple pregnancies, the relative contribution of each
of these is unknown [4].
Differences in the efficacy of PTB prevention strategies between singleton and twin preg-
nancies also suggest underlying mechanistic differences. Progesterone (P4) administration
reduces PTB in singletons [5] but not twins [6]. In PTB predictive tests, different cut-off values
of cervical length (CL) and fetal fibronectin (FFN) are used for singletons and twins, possibly
reflecting differing pathophysiological mechanisms causing the onset of spontaneous PTB.
A previous study [7] proposed that a single measurement (>2.1 ng/ml) of salivary estriol
(E3) could predict an increased risk of spontaneous PTB in singleton pregnancies. Three later
studies, two in saliva and one on serum, suggested that repeating measurements of hormones
to generate a “hormone profile” may be more useful than a single measure [8–10]. Priya et al.
and Lachelin et al. found that low saliva P4 between 24–34 weeks was associated with sponta-
neous PTB before 34 weeks [8,9]. Smith et al. found a significantly higher daily percentage
change in CRH at 26 weeks in preterm than term deliveries, and increased E3:E2 and
decreased P4:E3 ratios in the month before delivery [10]. Given this evidence, it would appear
that P4, E2, E3 and CRH profiling may be useful in predicting PTB. However, as these studies
were performed predominantly in singleton pregnancies (Smith et al. included 13 women with
multiple pregnancies in their cohort of 500 women), the potential for hormone profiles to pre-
dict PTB of twins is unknown. Our aim was to ascertain whether the time trends identified in
singletons (increased E3:E2 and decreased P4:E3 ratios in the month before delivery) applied
in twins, and if gestational hormone profiles could help predict PTB of twins.
We hypothesized that hormone profiles of P4, E2, E3 and CRH are different in twin preg-
nancies delivering preterm and at term and may serve as reliable markers for preterm birth
and/or spontaneous preterm birth in twin pregnancies. Both serum and saliva have been previ-
ously used to determine concentrations of steroids in pregnancy. Saliva is gaining increasing
recognition as a good alternative with diagnostic value [11], as it contains serum constituents
that reach the oral cavity via blood vessels and gingival fluid [12]. Steroids are highly stable in
saliva [13] and salivary sex steroids have been used in clinical settings to assess fertility and
ovarian function. Besides representing free and biologically-active hormone concentrations,
salivary specimen collection is non-invasive and convenient. Subjects can collect samples them-
selves as often as required and storage and transportation are convenient as thawing and re-
freezing cycles do not affect assays. A secondary aim was thus to compare serum and salivary
hormone profiles to determine if either was superior in prediction of preterm birth in twins.
Materials and methods
Ethical approval for the study and consent procedure was from the Lothian Regional Ethics
Committee (reference S1103) and the West of Scotland REC for the Edinburgh Reproductive
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our adherence to PLOS ONE policies on sharing
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Tissue BioBank (reference 09/50704/3). Written and verbal information was provided to par-
ticipants and written informed consent was obtained by the clinician involved in their care on
an approved consent form.
Women were enrolled from the specialist multiple pregnancy antenatal clinic at The Simp-
son’s Centre for Reproductive Health (SCRH), Royal Infirmary of Edinburgh between April
2010 and September 2011. The SCRH is a teaching hospital and tertiary referral center with
approximately 7000 deliveries per annum. All women with multiple pregnancies booked to
deliver in the hospital are cared for in a specialist multiple pregnancy clinic. Eligible women
were identified at their first clinic visit (usually at 11–16 weeks’ gestation) and invited to partic-
ipate. Informed consent was obtained by the clinician involved in their care. Five ml of blood
was collected via venepuncture and saliva was collected using Salivette kits (Sarstedt AG & Co,
Nu¨mbrecht, Germany) at each clinic attendance. The Salivette kits used (51.1534) contain an
untreated cotton swab in a collection tube. Saliva collections was performed as per manufac-
turers instructions—saliva is stimulated by chewing on a cotton swab for 60 seconds, returned
to the Salivette collection tube, and centrifuged for 2 minutes at 1,000 x g, with clear saliva col-
lected in sample tube, and particles and mucus strands collected in the tip of the Salivette tube.
Women were asked to refrain from eating for 30 minutes before sample collection. Sample col-
lection was pragmatic, with samples requested whenever women attended clinic for consulta-
tion. For most participants visits were scheduled at 16, 20, 28, 32 and 36 weeks’ gestation.
Inclusion and exclusion criteria
Inclusion criteria were age of16, twin pregnancy with chorionicity and gestation established
on ultrasound scan before 16 weeks’ gestation, gestation of less than 20 weeks at recruitment,
no known serious congenital abnormality and intending to deliver at the SCRH. Subjects who
tested positive for HIV, Hepatitis B or C or who were on progesterone therapy were excluded.
Further pre-specified exclusion criteria were applied after sample collection. As an aim was to
assess hormone profiles and interpolated values from 26 weeks gestation, subjects with gesta-
tional length less than 26 weeks or fewer than 3 blood or 3 saliva measurements were excluded
from analysis, in accordance with previously published criteria [10].
Clinical data
Clinical data was collected prospectively from electronic patient records (TrakCare) and
recorded on case report forms. Pregnancy outcome data included gestation at delivery, pre-
term delivery (<37 weeks’ gestation), very preterm delivery (<34 weeks’ gestation), labor
onset (spontaneous or iatrogenic), pregnancy complications and maternal medical conditions
(pre-eclampsia, suspected fetal growth restriction, diabetes, other), delivery method and birth
weight. Potential confounding factors collected included age, body mass index (BMI), parity
and smoking status.
Hormone measurement
Samples were centrifuged at 4˚C, 3000g for 15 minutes, with supernatants aliquoted and stored
at -80˚C until processing. Saliva and serum P4, E2 and E3 were measured by competitive
immunoassay using commercial Enzyme-Linked Immunosorbent Assay kits (Demeditec
Diagnostics GmbH, Kiel, Germany; Total E2 DE3355, Saliva E2 DESLV4188, Total P4DE1561,
Saliva P4 DES6633, Total E3 DE3717, Saliva E3 DES6644) according to manufacturer’s proto-
col. Analytical sensitivity of assays were 0.045ng/ml, 9.714pg/ml and 0.22ng/ml for serum P4,
E2 and E3 respectively, and 5.0pg/ml, 0.4pg/ml and 1.0pg/ml for saliva P4, E2 and E3 respec-
tively. Where sample hormone concentrations exceeded the assay dynamic range, they were
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diluted with charcoal-stripped human serum and incubation buffer for serum and saliva sam-
ples respectively. All kits performed as reported by the manufacturer, with intra- and inter-
assay coefficients of variation (CV) of under 6% and approximately 8% respectively across the
working range. CRH assays were performed on two plasma samples per subject using radioim-
munoassay according to the previously published protocol [10]. Assays were conducted blind
to pregnancy outcome and samples were analyzed in duplicates, with intra- and inter-assay
CV of 7.6% and 9.8% respectively.
Statistical analysis
Sample size was calculated based on differences in median concentrations of CRH in singleton
pregnancies that deliver at term and preterm (5pmol/L with a standard deviation of 4.296)
[10]. We calculated that a sample size of 70 (to achieve 10 spontaneous PTBs before 34 weeks
and 51 deliveries after 34 weeks) would have 95% power to detect this difference. Interim
assessment of recruitment revealed fewer women delivered spontaneously preterm than antici-
pated, and fewer women with preterm deliveries donated three samples, thus recruitment was
continued to a total of 121 to ensure adequate power. All statistical analyses were performed
using SPSS Statistics 22.0. Curve-fitting was used to obtain hormone trajectories, a single
smoothed curve representative of hormone concentrations across gestation of a number of
subjects. Our previously described hormone-specific equations (S1 Table Supplementary)
were used to transform trajectories into linear functions, under the assumption that a single
equation type could be used to curve-fit samples for each analyte [10]. Graphs were visually
checked for linearity to confirm the general validity of these equations. 26-week concentra-
tions derived from hormone trajectories were used for subsequent analyses.
Hormone concentrations, hormone ratios (P4:E2, P4:E3 and E3:E2) and derived variables
of CRH (rate, daily percentage change) at 26 weeks were compared in women who delivered
very preterm (<34 weeks’ gestation), preterm (<37 weeks’ gestation) and at term (37+ weeks’
gestation). The Mann-Whitney U test was used to identify significant differences. Differences
in variables were compared across the three groups with one-way ANOVA for continuous var-
iables and chi-square for categorical variables. To test PTB prediction potential, the relation-
ship between 26-week hormone concentrations and gestation at delivery was determined by
Spearman’s rank correlation coefficient analysis. Salivary and serum hormone concentrations
were also compared with Spearman’s coefficients.
Subgroup analysis
Similar but separate analyses were conducted for spontaneous PTBs, with medically indicated
preterm deliveries excluded.
Missing data
We pre-specified that women with fewer than 3 samples (n = 16), or missing delivery data
(n = 2) would be excluded. Hormone trajectories were modeled for each woman with3 sam-
ples, based on available hormone measurements (Fig 1).
Results
Two hundred and six women attended the multiple pregnancy clinic during the study period,
of whom 43 were ineligible for participation at the time of screening (20 being more than 20
weeks gestation; 23 with other exclusion criteria). Forty-two women declined participation
and 121 women were recruited to the study. Twenty- three women were subsequently
Placental hormones as predictors of twin preterm birth
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Fig 1. Hormone trajectories (smoothed median curves) in early preterm (n = 8), preterm (n = 40) and
term (n = 50) groups. Red lines, <34 weeks at delivery; green lines, 34-<37 weeks; blue lines, 37+ weeks.
(A) Salivary concentrations (n = 7, 35, 43 for <34, 34-<37 and 37+ weeks respectively). (B) Salivary ratios. (C)
Serum concentrations (n = 8, 41, 43 for <34, 34-<37, 37+ weeks respectively). (D) Serum ratios. (E) CRH
concentrations and derived variables.
doi:10.1371/journal.pone.0173732.g001
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excluded due to withdrawing midway (n = 4), having incomplete delivery data due to transfer
to another hospital (n = 2), delivery or fetal demise at less than 26 weeks’ gestation and/or hav-
ing fewer than three samples available for analysis (n = 17). This left a cohort of 98 women
with clinical and hormonal data for analysis.
Eight of 98 women delivered very preterm, 40 delivered preterm and 50 delivered at term.
Clinical details of the three groups are provided in Table 1. The groups were similar with
respect to maternal age, BMI, parity, smoking status and chorionicity (Table 1).
A total of 475 serum and 453 saliva samples from 98 subjects were analyzed, with the
median number of samples provided by each woman being four (range: 3–9) saliva and four
(range: 3–9) serum.
Normal hormone concentrations and trajectories in twin pregnancies
Previously described equations [10] (S1 Table) were suitable for curve-fitting, as evidenced by
the post-transformation linear graphs of hormone concentrations in 45 uncomplicated, full-
term twin pregnancies (S1 Fig).
Table 1. Maternal and fetal characteristics and pregnancy outcomes classified as early preterm, preterm and term deliveries.
Study cohort (n = 98) Early Preterm (<34 weeks) Preterm (34–36+6 weeks) Term (>37 weeks) p values
n 8 (8%) 40 (41%) 50 (51%)
Chorionicity
Dichorionic 7 (88%) 27 (68%) 42 (84%) 0.14
Maternal age (years) 33 ± 7.0 32 ± 5.4 33 ± 5.0 0.59
Maternal BMI (kg/m2) 24 ± 3.4 27 ± 5.9 25 ± 4.4 0.13
Parity
Primiparous 8 (50%) 25 (63%) 24 (49%) 0.41
Smoking, self-reported
Prior to pregnancy 3 (30%) 13 (33%) 15 (30%) 0.35
Current 0 (0%) 6 (15%) 3 (6%) 0.22
Outcomes
Complications 2 (25%) 21 (53%) 5 (10%) 0.00*
Pre-eclampsia or PIH 1 9 1 -
IUGR 1 5 0 -
Others 0 7 4 -
None 6 (75%) 19 (48%) 45 (90%) 0.09
Gestational age at delivery (weeks) 33 ± 1.30 36 ± 0.92 38 ± 0.62 0.00*
Labor onset
Spontaneous 6 (75%) 11 (28%) 6 (12%) 0.00*
Induction 0 9 (23%) 13 (26%) 0.26
Caesarean section 2 (25%) 20 (50%) 31 (62%) 0.12
Delivery method
Caesarean section 6 (75%) 32 (80%) 37 (74%) 0.68
Vaginal birth 2 (25%) 7 (18%) 13 (26%) 0.62
Vaginal, then caesarean 0 1 (3%) 0 -
Estimated blood loss (ml) 721 ± 378 788 ± 477 729 ± 490 0.83
Birth weight (g)
Twin 1 1964 ± 203 2363 ± 365 2775 ± 355 0.00*
Twin 2 2000 ± 303 2352 ± 350 2669 ± 426 0.00*
PIH, pregnancy-induced hypertension. p values obtained using one-way ANOVA for continuous variables, chi-squared tests for categorical variables.
*p < 0.001.
doi:10.1371/journal.pone.0173732.t001
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Preterm vs term comparisons
To compare preterm and term profiles, smoothed median curves of hormone concentrations
and ratios were used to illustrate hormone trajectories across gestation. On visual inspection,
trajectories in early preterm, preterm and term pregnancies were found to be largely similar
(Fig 1).
Estimated hormone concentrations and derived variables for each group were interpolated
at 26 weeks and compared. No significant differences were found between estimated P4, E2
and E3 concentrations and P4:E2, P4:E3 and E3:E2 ratios at 26 weeks in saliva and serum
when comparing preterm or early preterm pregnancies with term. The same was true for CRH
level, rate and percentage change. All asymptotic significance values exceeded 0.05 (Table 2).
A similar analysis restricted to spontaneous PTB (excluding iatrogenic PTBs) was con-
ducted and found no significant differences in hormone concentrations and ratios between
spontaneous PTBs and normal term deliveries. Asymptotic significance values are reflected in
Table 3.
Predictive value of hormone profiles
The ability of hormone profiles to predict preterm delivery was assessed using Spearman’s
rank correlation coefficients. All values were non-significant (Table 4), indicating that no sali-
vary or serum hormone level or derived variable correlated with the eventual time of delivery.
Ultimately, none of the absolute values or ratios of hormones investigated were able to predict
PTB.
Table 2. Median derived values of hormones at 26 weeks gestation in early preterm, preterm and term births, and comparisons between early pre-
term and term births, and preterm and term births.
Derived 26 week median hormone concentrations (nmol/l) and ratios (all
deliveries)
Preterm vs Term comparisons
Early Preterm (<34 weeks) Preterm (34–36+6 weeks) Term (>37 weeks) Preterm vs Term Very preterm vs Term
n = 8 n = 40 n = 50 MWU Value p value MWU Value p value
Saliva
P4 4.58 4.16 3.51 790 0.141 192 0.158
E2 1.27 1.57 1.36 90 0.446 12 0.773
E3 1.22 1.47 1.37 211 0.899 17 0.773
P4:E2 5.83 3.72 2.98 106 0.933 2 0.149
P4:E3 6.04 3.11 2.82 157 0.214 4 0.176
E3:E2 0.96 0.939 1.15 49 0.478 10 0.88
Serum
P4 437.86 365.34 387.93 1123 0.582 144 0.242
E2 35.72 36.54 33.33 1166 0.806 182 0.761
E3 105.62 94.78 105.93 988 0.175 184 0.851
P4:E2 13.74 11.09 11.37 1125 0.592 167 0.52
P4:E3 3.7 3.88 3.65 1032 0.299 174 0.688
E3:E2 2.91 2.49 3.19 1026 0.279 192 1
CRH
CRH level 1.784 1.785 1.698 807 0.077 162 0.13
CRH rate 0.016 0.015 0.015 1004 0.842 167 0.16
CRH % rate of change 0.977 0.822 0.903 867 0.197 228 0.948
MWU, Mann-Whitney U.
doi:10.1371/journal.pone.0173732.t002
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Saliva vs serum comparisons
Salivary hormones represent the metabolically-active, free and unbound fraction of total
serum concentrations. To find out if salivary and serum data are congruous, we compared
concentrations in several individuals as well as overall trends in the entire cohort.
To obtain a comparison of salivary and serum hormone concentrations in an individual,
we selected five subjects with different gestations at delivery, mode of labor onset and compli-
cations and plotted their P4, E2 and E3 concentrations throughout gestation (Fig 2). Serum
concentrations were consistently higher than salivary concentrations. Of the three hormones,
E3 was found to be the most correlated in saliva and serum, exhibiting a significant correlation
in 4 of the 5 subjects.
To compare salivary and serum concentrations across the cohort, 26 week concentrations
of each hormone and ratio were interpolated and compared using the Spearman’s correlation
coefficient analysis. Only P4 and the P4:E2 ratio were found to have a positive correlation in
terms of their salivary and serum concentrations (p = 0.042 and p = 0.002 respectively)
(Table 5).
Discussion
We sought to determine whether placental hormone profiles could be used as predictive bio-
markers of PTB in twin pregnancies. Our data suggests that serial measurements of hormones
in saliva and serum do not function as markers of preterm or very preterm birth of twins.
Table 3. Median derived values of hormones at 26 weeks gestation in spontaneous early preterm, spontaneous preterm and term births, and com-
parisons between spontaneous early preterm and term births, and spontaneous preterm and term births.
Derived 26 week median hormone concentrations (nmol/l) and ratios
(spontaneous preterm births)
Spontaneous Preterm vs Term
comparisons
Sp Early PTB (<34 weeks) Sp PTB (34–36+6 weeks) All Term (>37 weeks) Preterm (n = 17) vs
Term (n = 50)
Early preterm (n = 6)
vs Term (n = 50)
n = 6 n = 11 n = 50 MWU Value p value MWU Value p value
Saliva
P4 4.4 3.91 3.51 310 0.351 94 0.208
E2 - 1.16 1.36 10 0.313 - -
E3 - 1.54 1.37 9 0.677 - -
P4:E2 - 4.7 2.98 8 0.208 - -
P4:E3 - 2.89 2.82 12 1 - -
E3:E2 - 1.43 1.15 3 0.329 - -
Serum
P4 390.28 385.77 387.93 409 0.912 137 0.787
E2 35.72 31.57 33.33 378 0.572 145 0.957
E3 105.62 94.23 105.93 311 0.148 127 0.64
P4:E2 13.74 12.22 11.37 368 0.477 128 0.608
P4:E3 3.7 5.07 3.65 321 0.194 128 0.66
E3:E2 2.91 2.82 3.19 374 0.612 137 0.847
CRH
CRH level 1.784 1.744 1.698 384 0.406 139 0.226
CRH rate 0.016 0.016 0.015 388 0.44 156 0.428
CRH % rate of change 0.977 0.834 0.903 432 0.896 185 0.932
MWU, Mann-Whitney U. -, insufficient data.
doi:10.1371/journal.pone.0173732.t003
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The curve-fitting equations described in a previous paper [10] based on full-term, sponta-
neous singleton deliveries were applicable to our data and adequately described term and pre-
term twin pregnancies. Both the previous and current studies found no significant differences
in estimated 26-week concentrations and ratios between preterm and term deliveries, suggest-
ing that any preterm-term differences in hormone concentrations are not large enough to dis-
tinguish them. The lack of predictive value in CRH and its derivatives indicated by our data
contrasts with the predictive role of percentage change in CRH suggested by the previous
paper in singletons, potentially representing the mechanistic differences between twins and
singletons. Both studies had similar exclusion criteria and similar statistical methods [7] were
employed as far as possible to make our findings directly comparable. We attempted to
increase assay uniformity by conducting CRH measurements in the same laboratory using the
same method.
In contrast to our findings, Lachelin et al. 2009 [9] found low saliva P4 to be a predictor of
spontaneous early PTB in women with higher PTB risk. Comparing our data with theirs sug-
gests that firstly, saliva P4 is significantly higher in twin pregnancies than in singletons and sec-
ondly, saliva P4 was lower in very preterm than term deliveries in singletons but not in twins.
This again suggests that there are intrinsic differences between twin and singleton pregnancies
with regards to hormone trajectories. This observed singleton-twin difference may be due to
higher median hormone concentrations in twins making preterm-term differences less evi-
dent. Median CRH concentrations have been found to be 3.4 times higher in twins [10], poten-
tially explaining the difference in ability of CRH to predict PTB of singletons and twins.
Our attempt to identify a predictive marker of PTB was based on blood and saliva samples
obtained on clinic attendance. This study design has several strengths. This practical and cost-
effective approach tests a sampling method that is feasible and easily adaptable for clinical use.
The use of standard commercial kits according to the manufacturer’s protocol for hormone
Table 4. Spearman’s correlation coefficient analysis to determine the relationship between predicted hormone concentrations at 26 weeks’ gesta-
tion and ultimate gestation at delivery.
All deliveries Median concentrations (nmol/l) and ratios Spearman’s correlation coefficient
analysis
Very Preterm (<34) n = 8 Preterm (34-<37) n = 40 Term (37+) n = 50 Spearman’s rho p value (2-tailed)
Saliva
P4 4.58 4.16 3.51 -0.128 0.233
E2 1.27 1.57 1.36 -0.214 0.257
E3 1.22 1.47 1.37 -0.076 0.634
P4:E2 5.83 3.72 2.98 0.131 0.489
P4:E3 6.04 3.11 2.82 -0.114 0.479
E3:E2 0.96 0.939 1.15 0.174 0.426
Serum
P4 437.86 365.34 387.93 0.021 0.836
E2 35.72 36.54 33.33 -0.051 0.618
E3 105.62 94.78 105.93 0.113 0.272
P4:E2 13.74 11.09 11.37 0.069 0.498
P4:E3 3.7 3.88 3.65 -0.069 0.504
E3:E2 2.91 2.49 3.19 0.095 0.354
CRH
CRH level 1.784 1.785 1.698 -0.159 0.132
CRH rate 0.016 0.015 0.015 -0.052 0.626
CRH % rate of change 0.977 0.822 0.903 0.092 0.384
doi:10.1371/journal.pone.0173732.t004
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level measurement ensures minimal inter-center variation. Prospective enrolment of subjects
allows a more reliable assessment of serial hormone measurements as a population-screening
tool. The demographics of this cohort are those of the Scottish Caucasian population, with an
average BMI of 25.4 kg/m2, whilst the PTB rate (49.0%) was slightly lower than that reported
in the National Centers for Health Statistics’ Vital Statistics Data files in the USA in 2013
(56.6%) [14].
Nevertheless, the study has some limitations. Pragmatic sample collection during clinic
attendance may have introduced a selection bias as some subjects may have required more
appointments or been more compliant in attendance, hence contributing more samples. It
also meant that the exact gestational ages at which samples were obtained could not be
Fig 2. Correlation of salivary and serum hormone concentrations in five individuals. Red lines, serum concentrations; blue lines,
saliva concentrations.R, Spearman’s correlation coefficient (rho) value. Sig., significance value. *, p < 0.05; **, p < 0.01.
doi:10.1371/journal.pone.0173732.g002
Table 5. Spearman’s correlation coefficient analysis comparing salivary and serum concentrations.
Predicted hormone concentrations at 26 weeks P4 E2 E3 P4:E2 P4:E3 E3:E2
n 85 30 40 30 39 23
Spearman’s rho 0.221 0.332 0.053 0.536 0.016 0.190
p value (2-tailed) 0.042* 0.073 0.744 0.002** 0.921 0.386
doi:10.1371/journal.pone.0173732.t005
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standardized for all subjects. Our study was potentially limited by the high incidence of iatro-
genic preterm birth and the low number of spontaneous preterm deliveries (n = 23). Neverthe-
less, this is broadly comparable to previous, larger-scale studies [14], and a post-hoc power
calculation found our study had greater than 90% power to determine the difference in hor-
mone concentrations between both very preterm(<34 weeks’ gestation) and term, and pre-
term(<37 weeks’ gestation) and term deliveries.
We observed a generally low correlation between salivary and serum hormone concentra-
tions, suggesting that they cannot act as substitutes of one another. This could be due to vary-
ing modes and extents of hormone transport from blood to saliva. Transport could occur via
passive diffusion or active transport and salivary concentrations may be further influenced by
reabsorption or dynamic changes in transport proteins nearing the time of delivery [15]. Pro-
posed mechanisms have thus far been speculative with no specific molecules or carrier proteins
identified.
A study of the saliva-serum relationship of sex steroids in singleton pregnancies showed
moderate but statistically significant correlations for P4, E2 and E3 (Pearson’s r = 0.65, 0.71,
0.71 respectively, n = 28) in women with singleton pregnancies at 32–38 weeks’ gestation [16].
This contrasts with our data in twins. The low correlation observed in our data may once
again represent differences in hormonal mechanisms between singleton and twin pregnancies.
Changes in concentrations of binding proteins e.g. sex hormone-binding globulin, corticoste-
roid-binding globulin may differ, resulting in lower correlation in twins. Different statistical
approaches to analyses in the two studies may also contribute to differences.
Our study provides the first detailed investigation of placental hormone profiles in twin
pregnancies. It has gathered a sizeable amount of valuable clinical and hormonal data on twin
pregnancies upon which further studies and analyses can be based upon. The study also
attempts to explore the complexities of investigating twin pregnancies as opposed to singletons
and the nature of the saliva-serum hormone relationship.
Further research should focus on elucidating singleton-twin differences in placental hor-
mones and the mechanisms involved in twin PTB. Potential predictive tests may benefit from
including known clinical risk factors e.g. previous PTB in addition to biochemical measure-
ments. Taking the clinical history into consideration in the development of a predictive test
may better account for the multifactorial nature of the mechanisms underlying PTB.
Conclusions
While we are unable to conclude that hormone profiles in preterm and term twin births are
similar, it is evident that any differences cannot be easily identified and harnessed as a diagnos-
tic tool. Significantly higher median hormone concentrations in twin pregnancies may mask
subtle changes and make hormone profiling less robust. Our findings may also suggest some
singleton-twin differences in hormonal mechanisms triggering delivery. In isolation, serial
hormone measurements in saliva or serum are unlikely to work as an effective predictive tool.
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